...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: A clinical future for RVX-2135 or just a pre-clinical tool

BDAZ - The way I heard it ZEN-3694 does everything RVX-2135 does and more.

tada

Share
New Message
Please login to post a reply